AVITA Medical, Inc. (AVH.AX)
AUD 2.9
(2.84%)
AUD 2.9
(2.84%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2022 | -17.24 Million USD | 77.43% |
| 2021 | -76.39 Million USD | 30.46% |
| 2020 | -109.86 Million USD | -53.19% |
| 2019 | -71.72 Million USD | -254.0% |
| 2018 | -20.26 Million AUD | -87.73% |
| 2017 | -10.79 Million AUD | -270.5% |
| 2016 | -2.91 Million AUD | 6.51% |
| 2015 | -3.11 Million AUD | -1540.24% |
| 2014 | -189.94 Thousand AUD | 94.47% |
| 2013 | -3.43 Million AUD | 64.55% |
| 2012 | -9.68 Million AUD | -15.03% |
| 2011 | -8.42 Million AUD | 37.79% |
| 2010 | -13.54 Million AUD | -312.13% |
| 2009 | -3.28 Million AUD | -17.08% |
| 2008 | -2.8 Million AUD | 68.16% |
| 2007 | -8.81 Million AUD | 15.58% |
| 2006 | -10.43 Million AUD | -64.01% |
| 2005 | -6.36 Million AUD | 0.0% |
| 2003 | -2.52 Million AUD | -20.41% |
| 2002 | -2.1 Million AUD | 36.06% |
| 2001 | -3.28 Million AUD | -0.66% |
| 2000 | -3.26 Million AUD | -57.87% |
| 1999 | -2.06 Million AUD | -6379.68% |
| 1998 | -31.89 Thousand AUD | 63.05% |
| 1997 | -86.32 Thousand AUD | -1743.18% |
| 1996 | -4683.47 AUD | 65.05% |
| 1995 | -13.39 Thousand AUD | 66.13% |
| 1994 | -39.56 Thousand AUD | 82.62% |
| 1993 | -227.57 Thousand AUD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 Q3 | -48.1 Million USD | -32.02% |
| 2023 Q1 | -26.17 Million USD | -51.79% |
| 2023 Q2 | -36.43 Million USD | -39.2% |
| 2022 Q2 | -34.2 Million USD | -49.96% |
| 2022 Q3 | -22.49 Million USD | 34.24% |
| 2022 Q4 | -17.24 Million USD | 23.33% |
| 2022 FY | -17.24 Million USD | 77.43% |
| 2022 Q1 | -22.8 Million USD | 70.15% |
| 2021 Q4 | -76.39 Million USD | -28.67% |
| 2021 Q1 | -113.81 Million USD | -94.48% |
| 2021 Q2 | -109.86 Million USD | 3.47% |
| 2021 FY | -76.39 Million USD | 30.46% |
| 2021 Q3 | -59.37 Million USD | 45.96% |
| 2020 Q2 | -71.72 Million USD | 0.0% |
| 2020 Q4 | -58.52 Million USD | 8.52% |
| 2020 Q1 | - USD | 100.0% |
| 2020 FY | -109.86 Million USD | -53.19% |
| 2020 Q3 | -63.97 Million USD | 10.8% |
| 2019 Q2 | -20.26 Million AUD | 28.69% |
| 2019 Q3 | - USD | 100.0% |
| 2019 FY | -71.72 Million USD | -254.0% |
| 2019 Q1 | -28.41 Million USD | -33.3% |
| 2019 Q4 | -84.58 Million AUD | 0.0% |
| 2018 Q4 | -21.31 Million AUD | 29.75% |
| 2018 FY | -20.26 Million AUD | -87.73% |
| 2018 Q3 | -30.34 Million USD | -181.16% |
| 2018 Q2 | -10.79 Million AUD | 27.21% |
| 2018 Q1 | -14.82 Million USD | -61.39% |
| 2017 Q3 | -11.77 Million USD | -304.32% |
| 2017 Q2 | -2.91 Million AUD | 23.15% |
| 2017 Q1 | -3.79 Million USD | 37.27% |
| 2017 FY | -10.79 Million AUD | -270.5% |
| 2017 Q4 | -9.18 Million AUD | 22.0% |
| 2016 Q2 | -3.11 Million AUD | 25.32% |
| 2016 FY | -2.91 Million AUD | 6.51% |
| 2016 Q3 | -8.39 Million USD | -169.3% |
| 2016 Q4 | -6.04 Million AUD | 27.98% |
| 2016 Q1 | -4.17 Million USD | 25.74% |
| 2015 Q3 | -7.71 Million USD | -3962.15% |
| 2015 Q1 | -2.96 Million USD | -112.66% |
| 2015 FY | -3.11 Million AUD | -1540.24% |
| 2015 Q4 | -5.61 Million AUD | 27.19% |
| 2015 Q2 | -189.94 Thousand AUD | 93.6% |
| 2014 Q1 | -3.64 Million USD | 39.49% |
| 2014 Q4 | -1.39 Million AUD | 18.19% |
| 2014 FY | -189.94 Thousand AUD | 94.47% |
| 2014 Q2 | -3.43 Million AUD | 5.85% |
| 2014 Q3 | -1.7 Million USD | 50.36% |
| 2013 Q2 | -9.68 Million AUD | 8.74% |
| 2013 Q4 | -6.02 Million AUD | 10.81% |
| 2013 Q3 | -6.76 Million USD | 30.23% |
| 2013 Q1 | -10.61 Million USD | 28.46% |
| 2013 FY | -3.43 Million AUD | 64.55% |
| 2012 Q1 | -8.23 Million USD | 25.65% |
| 2012 Q3 | -14.28 Million USD | -69.59% |
| 2012 FY | -9.68 Million AUD | -15.03% |
| 2012 Q4 | -14.84 Million AUD | -3.89% |
| 2012 Q2 | -8.42 Million AUD | -2.34% |
| 2011 FY | -8.42 Million AUD | 37.79% |
| 2011 Q2 | -13.54 Million AUD | 0.0% |
| 2011 Q4 | -11.07 Million AUD | 0.0% |
| 2010 Q4 | -2.92 Million AUD | 0.0% |
| 2010 FY | -13.54 Million AUD | -312.13% |
| 2010 Q2 | -3.28 Million AUD | 0.0% |
| 2009 FY | -3.28 Million AUD | -17.08% |
| 2009 Q2 | -2.8 Million AUD | 0.0% |
| 2009 Q4 | -3.77 Million AUD | 0.0% |
| 2008 FY | -2.8 Million AUD | 68.16% |
| 2008 Q2 | -7.64 Million AUD | 0.0% |
| 2008 Q4 | -3.76 Million AUD | 0.0% |
| 2007 FY | -8.81 Million AUD | 15.58% |
| 2007 Q4 | -9.36 Million AUD | 0.0% |
| 2007 Q2 | -10.43 Million AUD | 0.0% |
| 2006 Q4 | -12.7 Million AUD | 0.0% |
| 2006 FY | -10.43 Million AUD | -64.01% |
| 2006 Q2 | -6.36 Million AUD | 0.0% |
| 2005 FY | -6.36 Million AUD | 0.0% |
| 2005 Q4 | -9.94 Million AUD | 0.0% |
| 2004 Q2 | -2.52 Million AUD | 0.0% |
| 2004 Q4 | -9.99 Million AUD | 0.0% |
| 2003 Q4 | -5.3 Million AUD | 0.0% |
| 2003 FY | -2.52 Million AUD | -20.41% |
| 2002 Q4 | -2.1 Million AUD | 0.0% |
| 2002 FY | -2.1 Million AUD | 36.06% |
| 2001 FY | -3.28 Million AUD | -0.66% |
| 2001 Q4 | -3.28 Million AUD | 0.0% |
| 2000 Q4 | -3.26 Million AUD | 0.0% |
| 2000 FY | -3.26 Million AUD | -57.87% |
| 1999 Q4 | -2.06 Million AUD | 0.0% |
| 1999 FY | -2.06 Million AUD | -6379.68% |
| 1998 FY | -31.89 Thousand AUD | 63.05% |
| 1998 Q4 | -31.89 Thousand AUD | 0.0% |
| 1997 FY | -86.32 Thousand AUD | -1743.18% |
| 1997 Q4 | -86.32 Thousand AUD | 0.0% |
| 1996 FY | -4683.47 AUD | 65.05% |
| 1995 FY | -13.39 Thousand AUD | 66.13% |
| 1994 FY | -39.56 Thousand AUD | 82.62% |
| 1993 FY | -227.57 Thousand AUD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| 4DMedical Limited | -25.48 Million AUD | 32.33% |
| Adherium Limited | -6.1 Million AUD | -182.521% |
| Aroa Biosurgery Limited | -3.74 Million AUD | -360.243% |
| Atomo Diagnostics Limited | -3.6 Million AUD | -378.614% |
| Anteris Technologies Ltd | -28.49 Million AUD | 39.486% |
| Control Bionics Limited | -19.02 Thousand AUD | -90563.442% |
| CardieX Limited | 2.74 Million AUD | 727.967% |
| Compumedics Limited | 5.08 Million AUD | 439.021% |
| Cochlear Limited | -269.9 Million AUD | 93.61% |
| CleanSpace Holdings Limited | 698.59 Thousand AUD | 2568.68% |
| Cyclopharm Limited | -7.49 Million AUD | -129.973% |
| EMVision Medical Devices Ltd | -15.7 Million AUD | -9.839% |
| Nova Eye Medical Limited | -2.8 Million AUD | -515.489% |
| HeraMED Limited | -799.34 Thousand AUD | -2057.508% |
| Imricor Medical Systems, Inc. | 14.48 Million AUD | 219.079% |
| ImpediMed Limited | -23.48 Million AUD | 26.578% |
| InhaleRx Limited | -155.54 Thousand AUD | -10987.538% |
| LBT Innovations Limited | -604 Thousand AUD | -2755.298% |
| Micro-X Limited | 826.99 Thousand AUD | 2185.371% |
| Neurotech International Limited | -2.11 Million AUD | -717.16% |
| OncoSil Medical Limited | -4.43 Million AUD | -289.236% |
| PolyNovo Limited | -30.52 Million AUD | 43.506% |
| Respiri Limited | 413.68 Thousand AUD | 4268.832% |
| SomnoMed Limited | -15.16 Million AUD | -13.739% |
| Universal Biosensors, Inc. | -5.3 Million AUD | -225.154% |
| Uscom Limited | -1.53 Million AUD | -1026.723% |
| Visioneering Technologies, Inc. | -4.08 Million AUD | -322.391% |